Publication | Closed Access

A phase I/II clinical trial investigating the adverse and therapeutic effects of a postoperative autologous dendritic cell tumor vaccine in patients with malignant glioma

VaccinationNeuro-oncologyOncologyImmunologyMalignant GliomaVaccine TrialTherapeutic EffectsTherapeutic VaccineVaccine EfficacyImmunotherapyMedicineGlioma